Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes. 1994

H Nonaka, and A Mori, and M Ichimura, and T Shindou, and K Yanagawa, and J Shimada, and H Kase
Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Shizouka, Japan.

The potential of 8-(3,4-dimethoxystyryl)-1,3-dipropyl-7-[3H] methylxanthine ([3H]Kf17837S) as a highly selective antagonist radioligand for the adenosine A2A receptor was examined and compared with the properties of the adenosine A2A receptor agonist radioligand 2-[p-(2-[3H]carboxyethyl)phenethylamino]-5'-N-ethyl- carboxamidoadenosine ([3H]CGS21680). [3H]KF17837S specific binding to rat striatal membranes was saturable and reversible. Saturation studies showed that the binding of [3H]KF17837S occurred at a single site, with high affinity (Kd, 7.1 +/- 0.91 nM) and limited capacity (Bmax, 1.3 +/- 0.23 pmol/mg of protein). Adenosine receptor antagonist ligands competed with the binding of 1 nM [3H]KF17837S with the following order of activity: CGS15943 > KF17837S > N-[2-(dimethylamino)ethyl]-N-methyl- 4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)benzenesul fonamide > or = xanthine amine congener > 8-cyclopentyl-1,3-dipropylxanthine > 8-(noradamantan-3-yl)-1,3-dipropylxanthine > caffeine. Adenosine receptor agonists inhibited [3H] KF17837S binding in the following order: 5'-N-ethylcarboxamidoadenosine > or = CGS21680 > 2-phenylaminoadenosine > or = (R)- N6-phenylisopropyladenosine > N6-cyclopentyladenosine > (S)- N6-phenylisopropyladenosine. The Ki values of the antagonists for [3H]KF17837S binding and the rank order of potency were similar to those for [3H]CGS21680 binding. The affinities of the agonists were lower with [3H]KF17837S binding than with [3H] CGS21680 binding. However, a strong positive correlation (r = 0.98) was observed between the pharmacological profiles for these two radioligand assays. The inhibition curve for CGS21680 was best fitted to a two-component binding model and addition of GTP shifted the inhibition curve to the right, suggesting that [3H]KF17837S labeled two agonist coupling states. Other pharmacological agents had negligible affinities for the [3H]KF17837S binding site. Autoradiographic study of [3H]KF17837S binding using rat brain sections revealed that the binding site was highly enriched in the striatal region. These data indicate that [3H] KF17837S labels the adenosine A2A receptor in rat brain.

UI MeSH Term Description Entries
D008297 Male Males
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001345 Autoradiography The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed) Radioautography
D014970 Xanthines Purine bases found in body tissues and fluids and in some plants.
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

H Nonaka, and A Mori, and M Ichimura, and T Shindou, and K Yanagawa, and J Shimada, and H Kase
December 1979, Naunyn-Schmiedeberg's archives of pharmacology,
H Nonaka, and A Mori, and M Ichimura, and T Shindou, and K Yanagawa, and J Shimada, and H Kase
December 1989, The Journal of pharmacology and experimental therapeutics,
H Nonaka, and A Mori, and M Ichimura, and T Shindou, and K Yanagawa, and J Shimada, and H Kase
January 1987, Naunyn-Schmiedeberg's archives of pharmacology,
H Nonaka, and A Mori, and M Ichimura, and T Shindou, and K Yanagawa, and J Shimada, and H Kase
October 1993, European journal of pharmacology,
H Nonaka, and A Mori, and M Ichimura, and T Shindou, and K Yanagawa, and J Shimada, and H Kase
April 1996, British journal of pharmacology,
H Nonaka, and A Mori, and M Ichimura, and T Shindou, and K Yanagawa, and J Shimada, and H Kase
October 1994, Biochemical pharmacology,
H Nonaka, and A Mori, and M Ichimura, and T Shindou, and K Yanagawa, and J Shimada, and H Kase
November 1993, European journal of pharmacology,
H Nonaka, and A Mori, and M Ichimura, and T Shindou, and K Yanagawa, and J Shimada, and H Kase
October 1993, Neuroreport,
H Nonaka, and A Mori, and M Ichimura, and T Shindou, and K Yanagawa, and J Shimada, and H Kase
December 1996, Circulation research,
H Nonaka, and A Mori, and M Ichimura, and T Shindou, and K Yanagawa, and J Shimada, and H Kase
November 1989, Biochemical pharmacology,
Copied contents to your clipboard!